Biomedical subjects
M Briggs
Publications and source records attributed to M Briggs.
Endocrine effects on serum-vitamin-B 12 .
Explore the source record for details and available documents.
Vitamin C requirements and oral contraceptives.
Explore the source record for details and available documents.
Withdrawal depression in obese patients after fenfluramine treatment.
Measurements of subjective feeling in 20 patients receiving fenfluramine alternating with placebo and in 19 patients receiving phentermine alternating with placebo indicated that depression of mood occurred four days after fenfluramine withdrawal but no such depression was seen with phentermine.
Traced elements in human hair.
Explore the source record for details and available documents.
Effects of some tropical diseases on the urea index.
Explore the source record for details and available documents.
Ethnic differences in urinary oestrogens.
Explore the source record for details and available documents.
Steroid contraceptives and plasma carotenoids.
Explore the source record for details and available documents.
Plasma hormone concentrations in women receiving steroid contraceptives.
Explore the source record for details and available documents.
Steroid hormone concentrations in blood plasma from residents of Zambia, belonging to different ethnical groups.
Explore the source record for details and available documents.
Relationship between monoamine oxidase activity and sex hormone concentration in human blood plasma.
Explore the source record for details and available documents.
Preliminary studies on metabolic effects of a continuous-dose, progestogen-only, oral contraceptive.
Explore the source record for details and available documents.
Screening with reagent strips.
Explore the source record for details and available documents.
Effects of steroid pharmaceuticals on plasma zinc.
Explore the source record for details and available documents.
Drugs of dependence though not of abuse: fenfluramine and imipramine.
Measures of subjective feeling used by five patients indicated that depression of mood occurred about four days after fenfluramine withdrawal. An experiment in which another 11 patients took fenfluramine 80 mg for 28 days confirmed the depression, maximal on the fourth withdrawal day. It also indicated that in the first week of administration there was some mood elevation, but with feelings of impaired ability to concentrate. The drug reduced appetite and weight. A comparison is drawn with imipramine, which was found to induce initial and withdrawal changes of subjective experience (of dreaming) in six volunteers. It is suggested that certain mood-influencing drugs may not be drugs of abuse because of some unpleasant initial effects, though they can be drugs of dependence.
Prevention of delayed traumatic facial palsy.
A previous impression that corticotrophin provided prophylaxis against delayed traumatic facial palsy has now been confirmed by the results obtained from the first 50 patients so treated.
The early management of head injuries.
Explore the source record for details and available documents.
Contraceptives and serum proteins.
Explore the source record for details and available documents.